Training Requirements for Theranostics: A Unique Opportunity for Collaboration.
作者信息
Graham Michael M, Buatti John M
机构信息
Department of Radiology, University of Iowa, Iowa City, Iowa; and
Department of Radiation Oncology, University of Iowa, Iowa City, Iowa.
出版信息
J Nucl Med. 2019 Sep;60(9):1205-1206. doi: 10.2967/jnumed.119.228940. Epub 2019 Apr 6.
Abstract
摘要
相似文献
1
Training Requirements for Theranostics: A Unique Opportunity for Collaboration.诊疗一体化的培训要求：合作的独特机遇
J Nucl Med. 2019 Sep;60(9):1205-1206. doi: 10.2967/jnumed.119.228940. Epub 2019 Apr 6.
2
New training pathways to dual certification in nuclear medicine and radiology.通往核医学与放射学双重认证的新培训途径。
J Nucl Med. 2015 Jun;56(6):17N-18N.
3
Differentiated thyroid cancer theranostics: radioiodine and beyond.分化型甲状腺癌的诊疗一体化：放射性碘及其他
Br J Radiol. 2018 Nov;91(1091):20180136. doi: 10.1259/bjr.20180136. Epub 2018 Oct 11.
4
5
Training of physicians for the practice of nuclear medicine, the USA experience.美国核医学实践医师培训经验
Nucl Med Commun. 1992 Jan;13(1):2-3.
6
Nuclear medicine.核医学
Clin Privil White Pap. 2009 Jun(146):1-20.
7
Nuclear medicine.核医学
Clin Privil White Pap. 2015 Oct(146):1-19.
8
[Postgraduate training in Nuclear Medicine: under the perspective of the resident physician].
Rev Esp Med Nucl Imagen Mol. 2015 May-Jun;34(3):197-8. doi: 10.1016/j.remn.2014.12.006. Epub 2015 Jan 24.
9
Appropriate Use Criteria for Nuclear Medicine in the Evaluation and Treatment of Differentiated Thyroid Cancer.分化型甲状腺癌评估与治疗中核医学的合理使用标准
J Nucl Med. 2020 Mar;61(3):375-396. doi: 10.2967/jnumed.119.240945.
10
本文引用的文献
1
Implementation of patient dosimetry in the clinical practice after targeted radiotherapy using [Lu-[DOTA0, Tyr3]-octreotate.使用[镥-[DOTA0, Tyr3]-奥曲肽]进行靶向放疗后在临床实践中实施患者剂量测定。
EJNMMI Res. 2018 Nov 29;8(1):103. doi: 10.1186/s13550-018-0459-4.
2
PSMA Theranostics: Current Status and Future Directions.前列腺特异性膜抗原诊疗学：现状与未来方向
Mol Imaging. 2018 Jan-Dec;17:1536012118776068. doi: 10.1177/1536012118776068.
3
Development and Validation of RAPID: A Patient-Specific Monte Carlo Three-Dimensional Internal Dosimetry Platform.开发与验证 RAPID：一个患者特异性蒙特卡罗三维体内剂量计算平台。
Cancer Biother Radiopharm. 2018 May;33(4):155-165. doi: 10.1089/cbr.2018.2451. Epub 2018 Apr 25.
4
Theranostic radiopharmaceuticals: established agents in current use.诊疗用放射性药物：当前正在使用的已确立的药物。
Br J Radiol. 2018 Nov;91(1091):20170969. doi: 10.1259/bjr.20170969. Epub 2018 Mar 12.
5
Somatostatin Receptor Antagonists for Imaging and Therapy.用于成像和治疗的生长抑素受体拮抗剂
J Nucl Med. 2017 Sep;58(Suppl 2):61S-66S. doi: 10.2967/jnumed.116.186783.
6
Targeted Radionuclide Therapy: An Evolution Toward Precision Cancer Treatment.靶向放射性核素治疗：向精准癌症治疗的演进
AJR Am J Roentgenol. 2017 Aug;209(2):277-288. doi: 10.2214/AJR.17.18264. Epub 2017 May 2.
Zotero 插件